| Expression pattern: |
UP |
| Associated gene: |
- |
| Associated microRNA: |
miR-145 |
| Biological function: |
hsa_circ_0003288 promotes NSCLC cell proliferation, colony formation, migration, invasion and tumor growth, and inhibits apoptosis. |
| Molecular mechanism: |
hsa_circ_0003288 acts as an oncogene by directly targeting and negatively regulating miR-145. |
| Biological pathway or process: |
proliferation (promotes); apoptosis (inhibits); migration (promotes); invasion (promotes); ceRNA regulation (other) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Clinical Sample Validation; Bioinformatics Analysis; Luciferase Reporter Assay; Transfection; MTT; Colony Formation Assay; Transwell Assay; TUNEL; In Vivo Animal Model |
| Clinical significance: |
hsa_circ_0003288 is significantly elevated in NSCLC tissues and may provide a novel therapeutic target for treatment of lung cancer. |
| Description: |
hsa_circ_0003288 is up-regulated in NSCLC tissues and lung cancer cell lines. It functions as an oncogenic circRNA that promotes proliferation, colony formation, migration, invasion and tumor growth while suppressing apoptosis. Mechanistically, it directly targets and negatively regulates miR-145, forming a hsa_circ_0003288/miR-145 axis in NSCLC progression. |
| Confidence score: |
0.6536 |